Biotechnology Spruce Biosciences’ Hormone Treatment Stumbles In Trials, Prompts Stock Freefall Spruce Biosciences’ Hormonal Disorder Candidate’s Future in Limbo: Analysts Downgrade Amid Tildacerfont’s Trial Setback – Spruce Biosciences (NASDAQ:SPRB) Read more
Biotechnology Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410 – Ocugen (NASDAQ:OCGN) Read more
Stockmarkets Phio Pharmaceuticals expands clinical trial sites for cancer study By biedexmarkets.com Read more
Cannabis Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments – SciSparc (NASDAQ:SPRC), Tikun Olam Cannbit (OTC:TKUNF) Read more
Eurozone Amsterdam Not Included In Government’s Legal Cannabis Trial, And More Marijuana Updates Across Europe – Curaleaf Holdings (OTC:CURLF) Read more
Biotechnology NodThera’s NLRP3 Inhibitor NT-0796 Reverses Neuroinflammation in Parkinson’s Disease Phase Ib/IIa Trial Read more
Biotechnology Novo Nordisk’s Stock Hits 52-Week High After Highly Sought After Obesity Drug Trial Data Why Novo Nordisk Stock Is Trading Higher Today – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Promising HIV Treatment: Phase 2 Clinical Trial Success for Gilead’s and Merck’s Combo Therapy – Merck & Co (NYSE:MRK), Gilead Sciences (NASDAQ:GILD) Read more